Phase II study of pirarubicin in untreated metastatic small cell lung carcinoma. Groupe Français de Pneumo-Cancérologie (GFPC)
Kleisbauer
J P
JP
Vergeret
J
J
Balmes
P
P
Reynaud-Gaubert
M
M
Taytard
A
A
Targhetta
R
R
Thomas
P
P
Bonnaud
F
F
Poirier
R
R
D018288:Carcinoma, Small Cell / Q000188:drug therapy* / Q000556:secondary; D004317:Doxorubicin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000556:secondary
D004317:Doxorubicin; C027260:pirarubicin